Please assess the completion status of the following clinical trial:

Trial Title: 10% Lidocaine Spray for Intrauterine Device Insertion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Woman who required for Copper T IUD insertion~* Body mass index 18.5 - 30 kg/m2~* Communicable with Thai language~* New IUD user~Exclusion Criteria:~* Suspicion of pregnancy~* Puerperal sepsis/Immediate post-septic abortion~* Untreated abnormal uterine bleeding~* Uterine anomaly/abnormal pathology distorting the uterine cavity~* Current pelvic inflammatory disease~* Untreated cervicitis/vaginitis~* Wilson's disease~* Copper allergy~* known hypersensitivity to local anaesthetic~* Analgesic or anxiolytic use within the last 24 h before the procedure

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- group A (Type: EXPERIMENTAL): 10% lidocaine spray
- group B (Type: PLACEBO_COMPARATOR): sterile water

Based on this trial design, predict the completion outcome and termination type (if applicable).